Phivida [“fiii-vee-daa”] Holdings Inc (CSE:VIDA, OTCQX:PHVAF) is pleased to announce an exclusive national agreement with Natural Speciality Sales, an Acosta company. Natural Speciality Sales (NSS) is recognised as the industry leader in Natural/Specialty retail channel trade across the USA.

Phivida’s soon to be launched OKI brand of premium CBD products are now the exclusive CBD infused beverage brand and health supplements products represented by NSS. This establishes Phivida as the first CBD brand company to officially cross-over into national mainstream distribution across the USA, providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.


The NSS exclusive agreement provides access to a national network of retail stores across the USA. This national network includes major retail banners such as; Whole Foods Market, Sprouts Farmers Market, and National Coop Grocers etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including; Walmart, Target, Kroger, Publix, and others, via Acosta’s national sales network.

NSS have established many of the strongest and fastest growing functional food and beverage brands in the marketplace, including; Kashi, Evolution Fresh (juices), Health Aide (Kombucha), Silk, Daiya, Zevia, Pacific, etc. OKI is Phivida’s new brand of CBD infused flavored iced tea, flavored infused waters along with tinctures and capsules destined for national retail channels. Phivida plans to unveil the OKI brand to consumers later in Q3 2018.

For similar success with OKI, Phivida and NSS are developing extensive retail sales and in-store marketing campaigns to maximize sell-through. This includes the execution and measurement of in-store merchandising, assortment, pricing, display, shelving services, in-store sampling, retail sales promotions, and related item placements for OKI products while maintaining all direct client relationships and in-store inventory levels.

With over 475 dedicated sales associates, managing 2,400 retail natural specialty grocery stores, Acosta’s Natural Specialty Sales division is recognized as the industry leader in strategic planning, headquarter sales, retail sales, analytics and customer service across all Natural/Specialty channels within the USA.

“This exclusive national agreement with Acosta and NSS is a major growth opportunity for Phivida, and a significant milestone for our industry overall,” said Phivida President and CEO, Jim Bailey. “Our partnership with NSS gives our premium products direct access to a growing national market of 2,400 total stores across the United States. In the short time we have worked with the NSS team, we have been impressed with the great people they have working there and are proud to partner with such a professional organisation. We are thrilled that Acosta/NSS have selected Phivida as their exclusive CBD beverage company, establishing Phivida’s new OKI label as the first CBD brand to officially cross-over into national mainstream distribution across the USA.”

John Caruso, National SVP – Business Development Strategic Channels, Caruso said, “CBD-hemp oil infused functional beverages and oil supplements are one of the most exciting new product lines we are bringing to the NSS division. Of all our channels, the Natural/Specialty market continues to grow at the fastest pace. We see enormous potential for CBD-infused beverages and Phivida is well positioned to be a market leader.”

“We believe that the team, the OKI brand, and the product quality and marketing strategy make Phivida a cut above the competition and the premier offering within this category. We are excited to bring the OKI products to health and wellness-minded consumers,” said Caruso. “It is these competitive differentiators that led our team to partner with Phivida. With this partnership, we are confident that OKI can be a market leader and the recognized and trusted brand in CBD-hemp infused functional foods and natural products, across North America.”

Phivida’s Chief Commercial Officer, Doug Campbell said, “There is no better partner than NSS to launch Phivida’s new OKI branded premium lifestyle range of products across the USA. With the collective experience NSS has in launching brands in the Natural/Specialty market we are now poised for success, and we couldn’t be more excited to partner with them. The product and marketing launch will begin within the Natural/Specialty channel, but we expect that conventional retailers, such as major national grocery stores, will soon follow.”

Acosta

Acosta is a privately held company founded in 1927 and has over 91 years of experience in consumer-packaged goods across the United States. Headquartered in Jacksonville, Florida, Acosta is seen as the industry leader in strategic planning, headquarter sales, retail sales, analytics and customer service support for a range of retail channels, including; natural specialty and conventional grocery, retail pharmacy, big box retail, food-club-mass drug (FCMD). Newly appointed CEO Rodriguez Bas brings more than 20 years of CPG and retail industry leadership to Acosta. Prior to joining Acosta, he was Executive Vice President of New Business and Market Development for C&S Wholesale Grocers, the nation’s largest wholesale grocery supply company, which delivers more than 140,000 different food and grocery items to 14,000 independent and chain stores across the U.S. During his time at C&S, Rodriguez Bas led the creation of a division that serves the natural, organic, specialty, gourmet and international, ethnic and local markets.

Acosta employs over 35,000 captive field force representatives and support staff, managing 49 routes and is a top food and beverage brokerage agency for top brands from Fortune 500 CPG companies like PepsiCo, Unilever, Proctor and Gamble and Kraft (etc.). Acosta has over 100 offices throughout the USA and Canada, responsible for over 200,000 in-store visits each month. The National Specialty Sales (NSS) division was founded in 2001 to provide sales and marketing solutions tailored to manufacturers of natural, organic, gourmet, regional specialty and ethnic foods and services over 2,400 Natural Specialty Grocery stores and over 25,000 Conventional Grocery Supermarket retail locations across the USA. For more information please visit https://www.acosta.com.

Phivida Holdings Inc.

Phivida [“fiii-vee-daa”] infuses CBD derived from Hemp into functional foods, beverages and health products. Phivida uses encapsulated cannabinoids from hemp oil into water soluble form, enhancing bioavailability, and timed released within the body. Phivida’s CBD beverages, foods and supplements contain a proprietary blend of phytonutraceuticals studied to target a range of health conditions, from chronic pain, treatment of stress and anxiety to reducing inflammation in the body.

The World Anti-Doping Association’s recently lifted a ban of CBD from hemp oil and the World Health Organization’s recent statement supports clinical benefits of CBD for athletes and active families.

Celebrating; Health and Wellness, In Harmony™, Phivida’s vision is to lead the market as the benchmark quality standard in premium CBD infused foods, beverages and clinical products, with a dedication to research, education and investing back into the communities we serve. Phivida is a publicly traded company listed on the Canadian Securities Exchange under the ticker symbol “VIDA” and the OTC Markets as “PHVAF”. For more information visit www.phivida.com (“Investors” in the footer) or join our social media network @Phivida.

Quick Facts:

For further information: Media Relations: Toll free: +1 (844) 744-6646 (ext. #2), Email: IR@phivida.com, Website: www.phivida.com

 

Click here to connect with Phivida [“fiii-vee-daa”] Holdings Inc (CSE:VIDA, OTCQX:PHVAF) for an Investor Presentation. 

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its first quarter results for period ended Sept 30, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.

FY21 First Quarter Financial Highlights

Keep reading... Show less

Signed LOI for CAD$23 million sale to Ionic provides shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce that it has received and signed a non-binding letter of intent dated November 30, 2020 with IONIC Brands Corp. (“Ionic”) for the proposed sale to Ionic of certain assets held by Lobe related to Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) (the “Transaction”). Cowlitz is one of the top five licensed cannabis producersprocessors located in Washington State.

The assets being sold to Ionic may include, but are not limited to, the assignment of all property leases relating exclusively to Cowlitz’s business, the assignment of Lobe’s option agreement to acquire all of the outstanding shares of Cowlitz, and the assignment of other contracts and rights related exclusively to Cowlitz including service contracts and equipment leases (the “Assets“).

The Transaction is subject to several closing conditions, including but not limited to: (i) satisfactory due diligence by both Ionic and Lobe; (ii) completion of a definitive agreement with binding terms and conditions for the Transaction, including finalization of the specific Assets that will be sold and certain Cowlitz assets that may be retained by Lobe; (iii) all respective directors and officers of Lobe and Ionic entering into support agreements for the Transaction; (iv) approval by the boards of directors of both Lobe and Ionic; (v) the completion of a share consolidation by Ionic on a minimum of one new Ionic common share for every four and a half (4.5) old Ionic common shares (the “Ionic Consolidation“); (vi) the conversion of all Ionic debentures (with principal amount of approximately CAD$14.7 million) into a secured equity or a similar instrument (“Debt Conversion“); (vii) completion of a concurrent financing by Ionic for gross proceeds of at least US$2 million (the “Ionic Concurrent Financing“); (viii) Ionic having all cease trade orders issued against it lifted(2); (ix) Ionic applying to the CSE for requalification and qualifying for listing and resumption of trading(2); and (x) the receipt of all required shareholder and regulatory approvals, including the approval of the CSE. Following the closing of the Transaction, Ionic’s board of directors is expected to be comprised of five (5) members and Lobe will have the right to appoint two (2) directors to the Ionic board.

The sale price for the Assets shall be a minimum of CAD$23 million, payable through the issuance of Ionic post-consolidation common shares (being approximately 49% of Ionic’s estimated $47 million capitalization post-restructuring (after giving effect to the Ionic Consolidation and Debt Conversion)), prior to giving effect to the Ionic Concurrent Financing. Following the closing of the Transaction, it is expected that the Lobe will own approximately 49% of Ionic’s common shares, on a post-consolidation and pre-Ionic Concurrent Financing basis. Ionic is expected to have a minimum total capitalization valuation of CAD$47 million, pre-Ionic Concurrent Financing.

As previously announced, Lobe has been pursuing strategic alternatives for Cowlitz, aimed at maximizing its value to the Company. Cowlitz reported over US$14.6 million in gross sales revenues for the nine month period ended September 30, 2020, according to data provided on reports to the Washington State Department of Revenues(1). Lobe generates revenues through licensing and leasing agreements in place with Cowlitz.

Ionic is listed on the Canadian Securities Exchange(2) (the “CSE“) (CSE: IONC) and is a growing US-based cannabis company that focuses on premium cannabis products with current operations in Washington and Oregon. Ionic has completed a number of strategic synergistic acquisitions since 2019 aimed at growing revenues as a multi-state operator, and increasing their overall product lines and intellectual property portfolio. Ionic’s strategy has been focused on building a regionalized multistate operation of cannabis brands in the Pacific Northwest markets with an eye to expansion into other recreational markets and aggressive national expansion.

John Gorst, CEO of Ionic said, “We are excited about this opportunity to expand our presence in Washington State. Cowlitz has tremendous brand presence and following in Washington State, which we feel is a natural fit, complementing our existing operations. The combination will make us one of the largest premier cannabis companies in the Pacific Northwest markets. The acquisition of the Cowlitz Assets will represent a complimentary synergistic acquisition that achieves our goal of operational expansion and growth of our product portfolio.”

“The proposed transaction with Ionic is accretive to both parties, successfully meets our M&A initiatives and keeps Lobe active in the cannabis and overall transformation psychedelic medicine space,” states Tom Baird, CEO of Lobe. “The Transaction provides Lobe with significant ownership and board presence in Ionic. With its already significant operations in Washington State and Oregon, we feel Ionic’s proposed product expansion initiatives together with the addition of the Cowlitz Assets can lead to aggressive growth.”

About Ionic Brands Corp.

Ionic is dedicated to building a regionally based multi-state consumer-focused cannabis concentrate brand portfolio with strong roots in the premium and luxury segments of vape concentrates and edibles. The cornerstone brand of the portfolio, IONIC, is the #3 vaporizer brand in Washington State and has aggressively expanded throughout the Pacific Northwest of the United States. The brand is currently operating in Washington and Oregon. Ionic’s strategy is to be the leader of the highest-value segments of the cannabis market.

About Lobe Sciences Ltd.

Lobe is a growth-oriented research, technology & services company that provides financial, management, IP and branding support to businesses. The Company operates a portfolio of companies focused on developing transformational medicines and applies refined strategies to help partner companies reach their full potential. Based in Vancouver, BC, Lobe Sciences creates value through acquisitions and development of assets, products and technologies by leveraging its scientific, engineering, branding and operational expertise supported by strong capital markets acumen.

For further information please contact:

Lobe Sciences Ltd.
Thomas Baird, CEO
info@lobesciences.com
Tel: (949) 505-5623

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Disclaimer for Forward Looking Statements

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including statements regarding the future plans and objectives of the Company, the Company’s expectations surrounding its development of treatments and/or therapeutics for mTBI and PTSD, the proposed Transaction and terms with Ionic and estimated capitalization of Ionic and share value to Lobe, Ionic having its cease trader orders lifted and resumption for trading on the CSE, future sales and expected revenues of Cowlitz and enhancing its value to the Company, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulations. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment; and that the current Board and management may not be able to attain the Company’s corporate goals and objectives. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.

Keep reading... Show less